HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annotation matters: validating the discovery of cancer drivers.

Abstract
Advanced sequencing techniques have helped unveil numerous new, potential cancer driver mutations. However, manual curation and analysis of gene and protein annotation are essential to verify such discoveries. Our recent study of STK19 (Serine Threonine Kinase 19), a previously identified melanoma driver, is a clear example of the importance of such detailed analysis, with both STK19 gene and protein annotations in frequently used databases having been proven incorrect.
AuthorsMarta Rodríguez-Martínez, Jesper Q Svejstrup
JournalMolecular & cellular oncology (Mol Cell Oncol) Vol. 7 Issue 6 Pg. 1806679 (Aug 31 2020) ISSN: 2372-3556 [Print] United States
PMID33235910 (Publication Type: Journal Article)
Copyright© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: